Agency classClass IIOur severity:Moderate FDA (Drugs)·D-537-2014·Announced 2014-01-22

Aidapak Recalls Lactase Enzyme Tablets Due to Potential Label Mixup

Aidapak Services, LLC is recalling Lactase Enzyme Tablets because they may be mislabeled as other medications. The recall covers 2,872 tablets distributed in four western states.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported illnesses or injuries, which aligns with the rubric for moderate severity involving minor labeling errors or low-risk contamination.

Plain-English summary

Aidapak Services, LLC is recalling 2,872 Lactase Enzyme Tablets, 3000 units, Over The Counter (NDC 24385014976). The recall is due to a labeling error where the tablets may be potentially mislabeled as other products, including Benzocaine/Menthol Lozenges, Acetaminophen/Aspirin/Caffeine Tablets, or Guaifenesin ER Tablets.

The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington. The source text does not specify the exact number of affected units beyond the total quantity or report any illnesses or injuries associated with the mislabeling.

Consumers should check their medication labels for the specific NDC and pedigree codes listed in the recall notice. If the product matches the recalled description, consumers should stop using it and contact their pharmacist or the recalling firm for instructions on return or disposal.

The recalled product

Product: LACTASE ENZYME Tablet, 3000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 24385014976
Manufacturer: Aidapak Services, LLC
Category: Drug — Over-the-Counter Medication
Hazard: mis-labeling
Affected units: 2,872

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (15)

LACTASE ENZYME Tablet
3000 units has the following codes Pedigree: AD21846_31
EXP: 5/1/2014
Pedigree: W003721
EXP: 6/26/2014
Pedigree: AD30028_25
EXP: 5/7/2014
Pedigree: AD60240_36
EXP: 5/22/2014
Pedigree: W002700
EXP: 6/5/2014
Pedigree: AD46257_53
EXP: 5/15/2014
Pedigree: W003021
EXP: 6/12/2014.

Distribution

Distributed in 4 states:

Part of a larger recall action

This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 273 products in this recall →

Same manufacturer · Aidapak Services, LLC

See all →

Moderate
Aidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
Moderate
Levothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
Moderate
Aidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
Moderate
Aidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
Moderate
Simvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29

Same hazard · mis labeling